Frontiers in Genetics (Mar 2022)

Applications of Non-Coding RNAs in Patients With Retinoblastoma

  • Daniel Fernandez-Diaz,
  • Daniel Fernandez-Diaz,
  • Cristina Rodriguez-Vidal,
  • Paula Silva-Rodríguez,
  • Paula Silva-Rodríguez,
  • Laura Paniagua,
  • María José Blanco-Teijeiro,
  • María José Blanco-Teijeiro,
  • María Pardo,
  • María Pardo,
  • Antonio Piñeiro,
  • Antonio Piñeiro,
  • Manuel Bande,
  • Manuel Bande

DOI
https://doi.org/10.3389/fgene.2022.842509
Journal volume & issue
Vol. 13

Abstract

Read online

Retinoblastoma (RB) is the most common primary intraocular malignancy in childhood. In the carcinogenic process of neoplasms such as RB, the role of non-coding RNAs (ncRNAs) has been widely demonstrated recently. In this review, we aim to provide a clinical overview of the current knowledge regarding ncRNAs in relation to RB. Although ncRNAs are now considered as potential diagnostic biomarkers, prognostic factors, and therapeutic targets, further studies will facilitate enhanced understanding of ncRNAs in RB physiopathology and define the roles ncRNAs can play in clinical practice.

Keywords